Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

10368	Companies
216044	Keywords
145764	Articles
114402	Press releases

Home
Companies
Biophytis

REGULATED PRESS RELEASE

published on 06/10/2024 at 08:18, 1 year 10 months ago

Biophytis annonce le dépôt d'une demande d'IND auprès de la FDA pour son étude de phase 2 dans l'obésité
Biophytis annonce le dépôt d'une demande d'IND pour son étude de phase 2 dans l'obésité auprès de la FDA. L'étude évalue l'efficacité de BIO101 chez des patients obèses et en surpoids

FDA Biophytis Étude De Phase 2 BIO101 Obésité
REGULATED PRESS RELEASE

published on 06/10/2024 at 08:18, 1 year 10 months ago

Biophytis announces filing of an IND application with the US FDA for its phase 2 study in obesity
Biophytis files IND application with US FDA for phase 2 obesity study with BIO101 (20-hydroxyecdysone) to assess muscle strength improvement in lower limbs and secondary endpoints like mobility and body composition

FDA Biophytis BIO101 IND Application Obesity Study
PRESS RELEASE

published on 06/10/2024 at 08:16, 1 year 10 months ago

Biophytis annonce le dépôt d'une demande d'IND auprès de la FDA pour son étude de phase 2 dans l'obésité
Biophytis annonce le dépôt d'une demande d'IND auprès de la FDA pour son étude de phase 2 dans l'obésité

FDA Biophytis Étude De Phase 2 Obésité Demande D'IND
PRESS RELEASE

published on 06/10/2024 at 08:16, 1 year 10 months ago

Biophytis announces filing of an IND application with the US FDA for its phase 2 study in obesity
Biophytis submits IND application to US FDA for phase 2 obesity study with BIO101 (20-hydroxyecdysone). Study to assess muscle strength & body composition. Research led by Professor Marc-André Cornier

Biophytis BIO101 IND Application Obesity Study Professor Marc-André Cornier
BRIEF

published on 06/07/2024 at 08:28, 1 year 11 months ago

Assemblée générale mixte de Biophytis le 24 juin 2024

Actionnaires Biophytis Biotechnologie Assemblée Générale Vote
BRIEF

published on 06/07/2024 at 08:28, 1 year 11 months ago

Biophytis Announces Combined General Meeting on June 24, 2024

Shareholders Biophytis General Meeting Voting Agenda
REGULATED PRESS RELEASE

published on 06/07/2024 at 08:23, 1 year 11 months ago

Assemblée générale mixte du 24 juin 2024
Biophytis SA tiendra son Assemblée Générale Mixte le 24 juin 2024 à Paris. Les actionnaires sont encouragés à voter en amont. La société se concentre sur le développement de traitements pour les maladies liées à l'âge

Assemblée Générale Mixte Biophytis SA Vote Actionnaires Traitements Maladies Liées À L'âge Développement Candidats Médicaments
REGULATED PRESS RELEASE

published on 06/07/2024 at 08:23, 1 year 11 months ago

Combined General Meeting of June 24, 2024
Biophytis SA to hold Combined General Meeting (CGM) on June 24, 2024 in Paris. Shareholders encouraged to vote in advance via multiple methods. Details available on the company's website

Shareholders Voting Combined General Meeting Biophytis SA CGM
BRIEF

published on 06/07/2024 at 07:44, 1 year 11 months ago

Assemblée générale mixte de Biophytis prévue le 24 juin 2024

Actionnaires Biophytis Paris Assemblée Générale Vote
BRIEF

published on 06/07/2024 at 07:44, 1 year 11 months ago

Biophytis Combined General Meeting scheduled for June 24, 2024

Shareholders Biophytis Paris General Assembly Vote

Accesswire

Published on 05/08/2026 at 01:50, 8 hours 23 minutes ago

Apex Critical Metals Announces Grant of Stock Options and RSUs
Published on 05/08/2026 at 00:45, 9 hours 28 minutes ago

Route1 Announces First Quarter 2026 Financial Results Notification
Published on 05/08/2026 at 00:00, 10 hours 13 minutes ago

Redwood AI Approved to Receive National Research Council of Canada Funding for its Q-SAFE Chemical Screening Project for Defence and Security Applications
Published on 05/07/2026 at 23:30, 10 hours 43 minutes ago

Faraday Copper Reports First Quarter 2026 Financial Results
Published on 05/07/2026 at 23:15, 10 hours 58 minutes ago

BULGOLD Adopts Semi-Annual Financial Reporting

View all ACCESSWIRE

EQS Group

Published on 05/08/2026 at 10:08, 4 minutes ago

Previewing the Product Logic Behind Waton’s Next AI Trading Platform
Published on 05/08/2026 at 10:00, 12 minutes ago

Original-Research: Finexity AG (von GBC AG): Buy
Published on 05/08/2026 at 10:00, 12 minutes ago

Sto SE & Co. KGaA: Unfavourable weather conditions and construction downturn at the start of the year impact business development in the first quarter of 2026
Published on 05/08/2026 at 10:00, 13 minutes ago

swissnet Group Signs Framework Agreement for Intelligent Video Solutions in the Smart Environment Sector
Published on 05/08/2026 at 09:44, 28 minutes ago

Turkiye Garanti Bankasi A.S.: Task Allocation of Investor Relations Unit

Les Echos

Published on 05/07/2026 at 19:15, 14 hours 58 minutes ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 14 hours 58 minutes ago

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 15 hours 7 minutes ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 15 hours 7 minutes ago

Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 15 hours 13 minutes ago

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE